View in EDS

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Saved in:

Bibliographic Details
Title:	Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
Authors:	Papachristofilou, Alexandros¹, Hipp, Madeleine M.², Klinkhardt, Ute², Früh, Martin³, Sebastian, Martin⁴, Weiss, Christian⁴, Pless, Miklos⁵, Cathomas, Richard⁶, Hilbe, Wolfgang⁷, Pall, Georg⁸, Wehler, Thomas⁹, Alt, Jürgen⁹, Bischoff, Helge¹⁰, Geißler, Michael¹¹, Griesinger, Frank^12,13, Kallen, Karl-Josef¹⁴, Fotin-Mleczek, Mariola², Schröder, Andreas², Scheel, Birgit², Muth, Anke²
Source:	Journal for ImmunoTherapy of Cancer. 12/1/2019, Vol. 7 Issue 1, p1-14. 14p.
Database:	Academic Search Ultimate

Description
ISSN:	20511426
DOI:	10.1186/s40425-019-0520-5